Author Question: Garrod hypothesized that "inborn errors of metabolism" such as alkaptonuria occu (Read 933 times)

Yolanda

  • Hero Member
  • *****
  • Posts: 757
Garrod hypothesized that "inborn errors of metabolism" such as alkaptonuria occur because
A) metabolic enzymes require vitamin cofactors, and affected individuals have significant nutritional deficiencies.
B) enzymes are made of DNA, and affected individuals lack DNA polymerase.
C) many metabolic enzymes use DNA as a cofactor, and affected individuals have mutations that prevent their enzymes from interacting efficiently with DNA.
D) certain metabolic reactions are carried out by ribozymes, and affected individuals lack key splicing factors.
E) genes dictate the production of specific enzymes, and affected individuals have genetic defects that cause them to lack certain enzymes.



coco

  • Hero Member
  • *****
  • Posts: 739

Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question

Yolanda

  • Hero Member
  • *****
  • Posts: 757

 

Did you know?

The Centers for Disease Control and Prevention has released reports detailing the deaths of infants (younger than 1 year of age) who died after being given cold and cough medications. This underscores the importance of educating parents that children younger than 2 years of age should never be given over-the-counter cold and cough medications without consulting their physicians.

Did you know?

A good example of polar molecules can be understood when trying to make a cake. If water and oil are required, they will not mix together. If you put them into a measuring cup, the oil will rise to the top while the water remains on the bottom.

Did you know?

The shortest mature adult human of whom there is independent evidence was Gul Mohammed in India. In 1990, he was measured in New Delhi and stood 22.5 inches tall.

Did you know?

Less than one of every three adults with high LDL cholesterol has the condition under control. Only 48.1% with the condition are being treated for it.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library